ES2183814T3 - Composicion farmaceutica que contiene il-6 y su uso para el tratamiento del trastorno trombohemorragico de consumo. - Google Patents

Composicion farmaceutica que contiene il-6 y su uso para el tratamiento del trastorno trombohemorragico de consumo.

Info

Publication number
ES2183814T3
ES2183814T3 ES93915854T ES93915854T ES2183814T3 ES 2183814 T3 ES2183814 T3 ES 2183814T3 ES 93915854 T ES93915854 T ES 93915854T ES 93915854 T ES93915854 T ES 93915854T ES 2183814 T3 ES2183814 T3 ES 2183814T3
Authority
ES
Spain
Prior art keywords
treatment
pct
trombohemorragic
pharmaceutical composition
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93915854T
Other languages
English (en)
Spanish (es)
Inventor
Jean-Claude Mestries
Francis Herodin
Serge Martin
Armaud Ythier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Applied Research Systems ARS Holding NV
Original Assignee
Applied Research Systems ARS Holding NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929214489A external-priority patent/GB9214489D0/en
Priority claimed from GB939301251A external-priority patent/GB9301251D0/en
Application filed by Applied Research Systems ARS Holding NV filed Critical Applied Research Systems ARS Holding NV
Application granted granted Critical
Publication of ES2183814T3 publication Critical patent/ES2183814T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES93915854T 1992-07-08 1993-07-08 Composicion farmaceutica que contiene il-6 y su uso para el tratamiento del trastorno trombohemorragico de consumo. Expired - Lifetime ES2183814T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929214489A GB9214489D0 (en) 1992-07-08 1992-07-08 Pharmaceutical compositions and uses therefor
GB939301251A GB9301251D0 (en) 1993-01-22 1993-01-22 Pharmaceutical compositions and use therefor

Publications (1)

Publication Number Publication Date
ES2183814T3 true ES2183814T3 (es) 2003-04-01

Family

ID=26301225

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93915854T Expired - Lifetime ES2183814T3 (es) 1992-07-08 1993-07-08 Composicion farmaceutica que contiene il-6 y su uso para el tratamiento del trastorno trombohemorragico de consumo.

Country Status (13)

Country Link
US (1) US5925344A (fr)
EP (1) EP0651648B1 (fr)
JP (1) JP3845112B2 (fr)
AT (1) ATE228848T1 (fr)
AU (1) AU674864B2 (fr)
CA (1) CA2139353C (fr)
DE (1) DE69332541T2 (fr)
DK (1) DK0651648T3 (fr)
ES (1) ES2183814T3 (fr)
IL (1) IL106272A (fr)
MX (1) MX9304075A (fr)
PT (1) PT651648E (fr)
WO (1) WO1994001123A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7108982B1 (en) 1999-02-19 2006-09-19 University Of Iowa Research Foundation Diagnostics and the therapeutics for macular degeneration
DE60031512T2 (de) * 1999-02-19 2007-08-23 University Of Iowa Research Foundation Diagnostika und therapeutika für maculare degeneration
EP1066834A3 (fr) * 1999-07-08 2004-06-02 Thomas Dr. Stief Compositions pharmaceutiques comprenant un agent modulateur des phagocytes
CN1434703A (zh) * 2000-08-24 2003-08-06 利统股份有限公司 延迟释放组合物及组合
FI20041425A0 (fi) * 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
DK2488203T3 (en) * 2009-10-16 2017-03-13 Omeros Corp METHODS OF TREATING DISSEMINATED INTRAVASCULAR COAGULATION BY INHIBITION OF MASP-2 DEPENDENT COMPLEMENT ACTIVATION
US9644035B2 (en) 2011-04-08 2017-05-09 Omeros Corporation Methods for treating conditions associated with MASP-2 dependent complement activation
RU2477530C2 (ru) * 2011-04-28 2013-03-10 Общество С Ограниченной Ответственностью "Научно-Производственная Фирма "Материа Медика Холдинг" Способ коррекции эндотелиальной дисфункции раствором гомеопатических разведений антител к интерлейкину-6

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5271931A (en) * 1988-09-14 1993-12-21 The Scripps Research Institute Methods for increasing C1 inhibitor concentrations using interferon-gamma and/or interleukin-6
JPH0372429A (ja) * 1988-10-07 1991-03-27 Chugai Pharmaceut Co Ltd 血小板減少症の治療剤
JP2805224B2 (ja) * 1989-01-13 1998-09-30 味の素株式会社 血小板減少症治療剤
US5087448A (en) * 1989-02-02 1992-02-11 The Board Of Regents Of The University Of Oklahoma Enhancing growth of megakaryocytes in mammals using interleuking 6
JPH04218000A (ja) * 1990-02-13 1992-08-07 Kirin Amgen Inc 修飾ポリペプチド
US5188828A (en) * 1990-11-08 1993-02-23 Brigham And Women's Hospital Interleukin-6 to stimulate erythropoietin production
WO1992008483A1 (fr) * 1990-11-13 1992-05-29 The Children's Medical Center Corporation REDUCTION DE LA DEGENERESCENCE NEURONALE LIEE A LA PROTEINE β-AMYLOIDE PAR UN EFFET ANTAGONISTE SUR L'ACTIVITE NEURONALE PROVOQUEE PAR LE NGF
CA2098008A1 (fr) * 1991-10-09 1993-04-10 Tasuku Okamoto Agent de prevention ou de traitement de la tendance a l'hemorragie

Also Published As

Publication number Publication date
CA2139353A1 (fr) 1994-01-20
DE69332541D1 (de) 2003-01-16
WO1994001123A1 (fr) 1994-01-20
AU674864B2 (en) 1997-01-16
CA2139353C (fr) 2006-11-07
DE69332541T2 (de) 2003-04-17
JP3845112B2 (ja) 2006-11-15
EP0651648A1 (fr) 1995-05-10
MX9304075A (es) 1994-04-29
US5925344A (en) 1999-07-20
AU4566493A (en) 1994-01-31
DK0651648T3 (da) 2003-01-06
IL106272A (en) 1999-01-26
JPH08502028A (ja) 1996-03-05
EP0651648B1 (fr) 2002-12-04
PT651648E (pt) 2003-04-30
ATE228848T1 (de) 2002-12-15
IL106272A0 (en) 1993-11-15

Similar Documents

Publication Publication Date Title
ES2102813T3 (es) Composiciones farmaceuticas y dermocosmeticas que contienen calostro equino.
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
ITRM920155A0 (it) Composizione farmaceutica contenente 3-2 (dimetilammino) etil-n-metil-1h-indol-5-metansolfonammide, e relativo procedimento di preparazione e trattamento con essa di mammiferi.
ES2166111T3 (es) Uso de tiagabina para el tratamiento de trastornos del sueño.
ES2154287T3 (es) Procedimiento para modificar el crecimiento de los pelos y/o de los cabellos y composiciones utilizables a este efecto.
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
AR019818A1 (es) Un inmunoconjugado de miostatina.
BR0009524A (pt) Uso de um composto, e, composição farmacêutica ou veterinaria
DE69311541D1 (de) Kosmetische oder pharmazeutische zusammensetzungen zur topischen anwendung die deacylierten glycerophospholipide enthalten
DK0663835T3 (da) Anvendelse af parathormon, dets biologisk aktive fragmenter og relaterede peptider til behandling af graviditet
ES2117243T3 (es) Nuevos antioxidantes fenolicos liquidos.
ES2183814T3 (es) Composicion farmaceutica que contiene il-6 y su uso para el tratamiento del trastorno trombohemorragico de consumo.
DK0688226T3 (da) Proteinpræparat til forebyggelse og terapi af periodontitis eller andre bakterielle patologier i mundhulen
PT1001775E (pt) Medicamento contendo ioimbina e arginina para tratamento de disfuncao erectil
ES2108122T3 (es) Composicion a base de amilina o de un analogo de amilina conteniendo opcionalmente insulina, para el tratamiento de la anorexia y de las patologias asociadas.
CZ157795A3 (en) Pharmaceutical preparations for treating prostatitis
ES2147796T3 (es) Composicion para el tratamiento o la prevencion del herpes.
HU9202026D0 (en) Method and medical preparative for treatment of thrombocytopenie
ES2157984T3 (es) Utilizacion de 4'-yodo-4'-desoxidoxorrubicina para el tratamiento de la amidoidosis.
BR0211323A (pt) Combinação de ingredientes ativos, uso de uma combinação de ingredientes ativos e método de terapia farmacológica de dependência de nicotina
UY23886A1 (es) Metodos de preparacion de trombopoyetina
ZA9427B (en) Use of riluzole for promoting restoration following radiation
ES2063079T3 (es) Una composicion farmaceutica que tiene efecto sinergico basada en sulbactam y metampicilina.
KR960033467A (ko) 뮤신분비 억제제
GEP19980954B (en) Ointment “Hypoaskane”